Common use of Undertaking Clause in Contracts

Undertaking. During the term of this Agreement, each party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreement

Appears in 4 contracts

Samples: Confidential Treatment Requested (Vertex Pharmaceuticals Inc / Ma), Research, Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma), Development and Commecialization Agreement (Royalty Pharma PLC)

AutoNDA by SimpleDocs

Undertaking. During the term of this Agreement, each party Party (the “Receiving Party”) shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed disclosed to the Receiving Party by the other partyParty (the “Proprietary Party”), whether in tangible or intangible form, the confidentiality of which such other party Proprietary Party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to Collaboration Intellectual Property.

Appears in 3 contracts

Samples: Collaboration and Option Agreement (Infinity Pharmaceuticals, Inc.), Collaboration and Option Agreement (Discovery Partners International Inc), Collaboration and Option Agreement (Discovery Partners International Inc)

Undertaking. During the term of this Agreement, each party (a “Receiving Party”) shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other partyparty (the “Proprietary Party”), whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to Collaboration Technology.

Appears in 3 contracts

Samples: Development and Commercialization Agreement (Myogen Inc), License, Development and Commercialization Agreement (Myogen Inc), Development and Commercialization Agreement (Myogen Inc)

Undertaking. During the term of this Agreement, each party shall keep confidential, and other than as provided herein herein, shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect ("Confidential Information"). Neither CFFT nor Vertex Predix will use the other party’s 's Confidential Information except as expressly permitted in this Agreement:

Appears in 3 contracts

Samples: Development and Commercialization Agreement (Predix Pharmaceuticals Holdings Inc), Research, Development and Commercialization Agreement (EPIX Pharmaceuticals, Inc.), Development and Commercialization Agreement (Predix Pharmaceuticals Holdings Inc)

Undertaking. During the term of this Agreement, each party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to VERTEX Technology and NOVARTIS Technology.

Appears in 3 contracts

Samples: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma), And Early Development Agreement (Vertex Pharmaceuticals Inc / Ma), Confidential Treatment (Vertex Pharmaceuticals Inc / Ma)

Undertaking. During the term of this Agreement, each party (the "Receiving Party") shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other partyparty (the "Proprietary Party"), whether in tangible or intangible form, the confidentiality of which such other party Proprietary Party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to Collaboration Technology.

Appears in 2 contracts

Samples: Collaboration and Option Agreement (Myogen Inc), Collaboration and Option Agreement (Myogen Inc)

Undertaking. During the term of this Agreement, each party Party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, Information owned, developed or possessed by the other partyParty, whether in tangible or intangible form, the confidentiality of which such other party Party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor protect, including but not limited to Vertex will use the other party’s Confidential Information except as expressly permitted in this AgreementTechnology and Avalon Technology.

Appears in 2 contracts

Samples: Commercialization Agreement (Avalon Pharmaceuticals Inc), License, Development and Commercialization Agreement (Avalon Pharmaceuticals Inc)

Undertaking. During the term of this Agreement, each party (a "Receiving Party") shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other partyparty (the "Proprietary Party"), whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to Collaboration Technology.

Appears in 2 contracts

Samples: Development and Commercialization Agreement (Myogen Inc), Development and Commercialization Agreement (Myogen Inc)

AutoNDA by SimpleDocs

Undertaking. During the term of this Agreement, each party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect ("Confidential Information"). Neither CFFT nor Vertex will use the other party’s 's Confidential Information except as expressly permitted in this Agreement

Appears in 1 contract

Samples: Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma)

Undertaking. During the term of this Agreement, each Each party shall keep confidential, and other than as provided herein herein, shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect form (“Confidential Information”). All Confidential Information shall be identified as such by the party disclosing such information. Neither CFFT nor Vertex CombinatoRx will use the other party’s Confidential Information except as expressly permitted in this Agreement. In addition:

Appears in 1 contract

Samples: Certain Confidential Information (Combinatorx, Inc)

Undertaking. During the term of this Agreement, each party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to VERTEX Know-How and HMR Know-How.

Appears in 1 contract

Samples: License, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)

Undertaking. During the term of this Agreement, each party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, owned, developed or possessed by the other party, whether in tangible or intangible form, the confidentiality of which such other party takes reasonable measures to protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreementprotect, including but not limited to VERTEX Kinase Technology and NOVARTIS Kinase Technology.

Appears in 1 contract

Samples: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma)

Time is Money Join Law Insider Premium to draft better contracts faster.